UnitedHealth Group Incorporated (NYSE:UNH) Holdings Lifted by Barlow Wealth Partners Inc.

Barlow Wealth Partners Inc. grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 29.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 47,460 shares of the healthcare conglomerate's stock after purchasing an additional 10,756 shares during the period. UnitedHealth Group makes up 3.2% of Barlow Wealth Partners Inc.'s investment portfolio, making the stock its 8th biggest holding. Barlow Wealth Partners Inc.'s holdings in UnitedHealth Group were worth $24,857,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in the company. Financial Management Professionals Inc. lifted its position in UnitedHealth Group by 0.8% in the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock valued at $1,165,000 after acquiring an additional 17 shares in the last quarter. Richwood Investment Advisors LLC lifted its holdings in shares of UnitedHealth Group by 0.4% in the fourth quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock valued at $2,654,000 after purchasing an additional 20 shares in the last quarter. Global Wealth Strategies & Associates grew its holdings in UnitedHealth Group by 28.6% during the first quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock worth $47,000 after buying an additional 20 shares in the last quarter. Kolinsky Wealth Management LLC lifted its stake in UnitedHealth Group by 1.0% during the 4th quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock valued at $1,080,000 after acquiring an additional 21 shares in the last quarter. Finally, Retirement Planning Group LLC grew its stake in shares of UnitedHealth Group by 5.1% in the 1st quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock worth $225,000 after acquiring an additional 21 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,533 shares of the business's stock in a transaction dated Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the acquisition, the director owned 6,033 shares of the company's stock, valued at $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CFO John F. Rex bought 17,175 shares of the company's stock in a transaction on Friday, May 16th. The shares were bought at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the transaction, the chief financial officer owned 203,796 shares of the company's stock, valued at $59,329,091.52. The trade was a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have bought 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is owned by insiders.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH traded up $1.13 during midday trading on Friday, reaching $308.69. 6,161,145 shares of the company traded hands, compared to its average volume of 7,543,771. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The firm's fifty day moving average price is $327.18 and its two-hundred day moving average price is $448.90. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The firm has a market capitalization of $280.03 billion, a price-to-earnings ratio of 12.93, a price-to-earnings-growth ratio of 1.46 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter last year, the business posted $6.91 earnings per share. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were paid a dividend of $2.21 per share. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 2.86%. UnitedHealth Group's dividend payout ratio (DPR) is currently 37.02%.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the stock. Wall Street Zen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Robert W. Baird lowered UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 target price for the company. in a report on Wednesday, June 11th. Raymond James Financial lowered UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. HSBC reaffirmed a "reduce" rating and set a $270.00 target price (down from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Finally, Bank of America lowered shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and reduced their price target for the company from $560.00 to $350.00 in a research report on Wednesday, May 14th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and a consensus target price of $415.57.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.